Stem Cell Therapy

BusinessStem Cell TherapyFurestem-RA


Furestem-RA® targets moderate to severe rheumatoid arthritis patients.  
Phase 1 was completed on 10/2015.
  • Product name : Furestem-RA®
  • Manufacturer : Kangstem Biotech
  • Target : Moderate to severe rheumatoid arthritis patients
  • Injection route : IV injection

MoA : Furestem-RA® suppress the activation of M1-type macrophage, which induces inflammation, and induce generation of M2-type macrophage via TNF-α-mediated activation of cyclooxygenase-2 (COX-2) and TNF-stimulated gene-6 (TSG-6). M2 macrophage suppress inflammatory symptoms and contribute to regeneration of damaged tissues.

whatwedo : furestemRA : : : /whatwedo/furestemRA